Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-000701
Filing Date
2020-01-17
Accepted
2020-01-16 20:25:58
Documents
24
Period of Report
2019-11-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8ka.htm 8-K/A 42196
2 ex23-1.htm EX-23.1 3342
3 ex23-2.htm EX-23.2 1282
4 ex23-2_001.jpg GRAPHIC 63128
5 ex99-1.htm EX-99.1 17763
6 ex99-2.htm EX-99.2 190405
7 ex99-1_001.jpg GRAPHIC 35861
8 ex99-1_002.jpg GRAPHIC 55588
9 ex99-1_003.jpg GRAPHIC 206105
10 ex99-1_004.jpg GRAPHIC 65938
11 ex99-1_005.jpg GRAPHIC 76268
12 ex99-1_006.jpg GRAPHIC 60810
13 ex99-1_007.jpg GRAPHIC 85341
14 ex99-1_008.jpg GRAPHIC 104704
15 ex99-1_009.jpg GRAPHIC 216878
16 ex99-1_010.jpg GRAPHIC 227088
17 ex99-1_011.jpg GRAPHIC 241132
18 ex99-1_012.jpg GRAPHIC 167899
19 ex99-1_013.jpg GRAPHIC 171943
20 ex99-1_014.jpg GRAPHIC 205318
21 ex99-1_015.jpg GRAPHIC 220247
22 ex99-1_016.jpg GRAPHIC 199223
23 ex99-1_017.jpg GRAPHIC 132839
24 ex99-1_018.jpg GRAPHIC 74223
  Complete submission text file 0001493152-20-000701.txt   3852913
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21990 | Film No.: 20532106
SIC: 2834 Pharmaceutical Preparations